CN2820130Y - Auricula sinistra blocking device capable of automatic positioning in auricula sinitra - Google Patents

Auricula sinistra blocking device capable of automatic positioning in auricula sinitra Download PDF

Info

Publication number
CN2820130Y
CN2820130Y CN 200620068478 CN200620068478U CN2820130Y CN 2820130 Y CN2820130 Y CN 2820130Y CN 200620068478 CN200620068478 CN 200620068478 CN 200620068478 U CN200620068478 U CN 200620068478U CN 2820130 Y CN2820130 Y CN 2820130Y
Authority
CN
China
Prior art keywords
left auricle
auricle
model
utility
stopper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200620068478
Other languages
Chinese (zh)
Inventor
孔祥清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200620068478 priority Critical patent/CN2820130Y/en
Application granted granted Critical
Publication of CN2820130Y publication Critical patent/CN2820130Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Prostheses (AREA)
  • Surgical Instruments (AREA)

Abstract

The utility model discloses a left auricle blocking device capable of automatic positioning in a left auricle against the problems that the combination is unreasonable, the left auricle is easy to damage when the existing heart left auricle blocking device is fixed, and an ulceration remaining residual cavity occurs easily at the point of an opening of the left auricle; the problems exist in the exiting heart left auricle blocking device. The left auricle blocking device capable of automatic positioning in a left auricle comprises isolating films (3). Each of the isolating films (3) is formed from nickel-titanium alloy wires in the knitting mode; a bracket (1) in the net-shaped structure is arranged on the surface of each of the isolating films (3), and each of the isolating films (3) is installed in the bracket (1). The utility model is characterized in that the bracket (1) is formed by that a hollow disk-shaped blocking head (6) is connected with a hollow cylindrical positioning column (5); the outer diameter of the disk disk-shaped blocking head (6) is bigger than that of the cylindrical positioning column (5). The isolating films (3) are installed in both of the disk-shaped blocking head (6) and the cylindrical positioning column (5). A transferring joint (2) is installed on one surface of the disk-shaped blocking head (6), which is not connected with the cylindrical positioning column (5). The utility model has the advantage of reasonable structure, and can be automatically positioned in the left auricle without the occurrence of operative complications. The utility model is suitable for left auricles of different sizes.

Description

Can be in left auricle automatic localized left atrial appendage occlusion device
Technical field
This utility model relates to a kind of medical apparatus and instruments, especially a kind of apparatus for the treatment of heart left auricle pathological changes, specifically a kind of can be in left auricle automatic localized left atrial appendage occlusion device.
Background technology
At present, chronic atrial fibrillation (AF) is a kind of common arrhythmia, and AF patient is the high-risk group of thromboembolic stroke, and 20% apoplexy is relevant with AF.The embolus of nonvalvular atrial fibrillation occurs in left auricle (LAA) more than 90%.Utilizing warfarin to carry out pharmaceutical intervention is the treatment means that can effectively prevent the AF apoplexy of generally acknowledging at present.But because warfarin causes hemorrhage complication height, need monitoring INR, pharmacological action is subjected to the influence of factors such as medicine, food and need takes all the life, makes its clinical practice be subjected to certain restriction.Prevented AF patient's thromboembolism to adopt surgery to open breast excision or ligation LAA in the past, big to patient trauma, and leave scar after the operation, routine is carried out simultaneously when generally only being recommended in chronic AF need operation on heart.In order to prevent oral warfarin anticoagulant therapy that the embolic complication of incompatible thromboembolism high-risk patient is arranged; calendar year 2001 U.S. Appriva Medical company has developed a kind of left atrial appendage occlusion device (PLAATO device); this is present unique left atrial appendage occlusion device, explores to use through cardiac catheter and sends into PLAATO device sealing left auricle.Though find that through zoopery and preliminary clinical application the PLAATO stopper is easy to use, certain curative effect is arranged, but because this stopper is a cage structure, its surface is provided with the fixedly anchor spline structure of usefulness, on the one hand, anchor spline structure around the nick-eltitanium alloy stent is easy to damage left auricle, causes complication such as cardiac tamponade; On the other hand, the cage spline structure of stopper is inserted in the left auricle when shutoff fully, exists the left auricle opening part to leave over the possibility of residual cavity, forms thrombosis in the residual cavity easily, still has the hidden danger of thromboembolism, and its profile can not satisfy the needs of anatomical cardiac principle; In addition, existing stopper can't also may form surperficial thrombosis at the quick endothelialization of the real realization in the back that implants.Therefore be necessary to be improved,, reduce patient's misery to benefit the patient.
Summary of the invention
The purpose of this utility model be at existing heart left atrial appendage occlusion device exist in conjunction with unreasonable, easy damaged left auricle and left auricle opening part are prone to the expensive problem of staying residual cavity in the time of fixedly, provide a kind of rational in infrastructure, have the plate-like block head, rely on construction features and material behavior to be positioned in the left auricle automatically simultaneously, postoperative complication can not appear, be suitable for simultaneously that different big or small left auricle use can be in left auricle automatic localized left atrial appendage occlusion device.
The technical solution of the utility model is
A kind of can be in left auricle automatic localized left atrial appendage occlusion device, comprise form by nitinol alloy wire braiding, the surface is for cancellated support 1 and be installed in isolating membrane 3 in the support 1, it is characterized in that described support 1 is linked to each other by the cylindrical reference column 5 of the plate-like block head 6 of hollow and hollow forms, and the external diameter of plate-like block head 6 is greater than the external diameter of cylindrical reference column 5; In plate-like block head 6 and cylindrical reference column 5, isolating membrane 3 is installed all; On the one side that the cylindrical reference column 5 of plate-like block head 6 discord links to each other, be equipped with and transmit union joint 2.
The molecule fibronectin that antithrombotic molecular heparin, hirudin is arranged and increase endothelialization at the pan coating of the nitinol alloy wire of braided support 1.
Described isolating membrane 3 is the polytetrafluoroethylene film.
At least be provided with two layers of isolating membrane 3 at described cylindrical reference column 5.
The edge of described isolating membrane 3 is sewn on cylindrical reference column 5 and the plate-like block head 6 by medical suture.
Stopper of the present utility model is formed by the memory alloy wire braiding of super-elasticity, self-expanding, and left room face is plate-like, and the auricle part is cylindrical, and the inner surface and the cylindrical interior of the plate-like face of stopper are covered with the polytetrafluoroethylene film respectively.The form of left auricle is irregular, and is not of uniform size, needs stopper that the model of different-diameter is arranged, to be fit to the left auricle of different sizes.Can stopper be fixed on left auricle reliably, and its determiner is to select the elastic force of volumetrical size of stopper and stopper timbering material thereof for use.So the diameter of stopper cylindrical part should be bigger by 20%~40% than left auricle inlet diameter, too little then device is unstable, the too big damage easily of elastic strength auricle.Therefore, when design and making stopper, fully take into account the thickness and the super-elasticity of nitinol alloy wire.In addition, also should consider the smooth smooth of stopper surface and how to prevent its surperficial thrombosis and promote the quick endothelialization on its surface.
The utlity model has following advantage:
1, stopper of the present utility model is to finish on the basis to the research of a large amount of people's left auricle anatomical structure, meets the left auricle structure, does not have the anchor spline structure, can better seal left auricle and avoid damaging left auricle, prevents complication such as cardiac tamponade.
2, this utility model passes through the covalency bags such as molecule fibronectin of antithrombotic molecular heparin, hirudin and increase endothelialization by the nick-eltitanium alloy stent surface, compare with existing left atrial appendage occlusion device, that has reduced the stopper surface may produce thrombotic complication, has quickened the endothelialization on the stopper surface of implantation.
3, saved the anchor spline structure on the structure of the present utility model, made its structure more simple, made more convenient.
4, the distinctive disk-like structure of this utility model has guaranteed the good shutoff to the left auricle opening part, therefore can not occur easily forming residual cavity after the existing stopper shutoff, more can not cause the generation of complication such as thrombosis.
5, the multi-layer isolation films that is arranged in plate-like block head and cylindrical reference column can stop blood flowing at left auricle effectively
6, the cylindrical structure in the disk-like structure that matches of of the present utility model and left atrium face import department and the auricle is linear when being subjected to the external force tractive, therefore installs very conveniently, can realize Minimally Invasive Surgery.Disk-like structure can cover the left auricle mouth fully and be close on the atrial walls after stopper discharges, cylindrical structure fills the left auricle chamber and unlikely slippage fully after release.
7, this utility model can be put into the transfer system of 8F, and the self-expanding function is arranged, and can recover the function of external shape after discharging outside transmitting sheath.
Description of drawings
Fig. 1 is a structural representation of the present utility model.
Fig. 2 is the vertical view of Fig. 1.
The specific embodiment
Following structure drawings and Examples are further described this utility model.
As shown in Figure 1, 2.
A kind of can be in left auricle automatic localized left atrial appendage occlusion device, mainly by nitinol alloy wire support 1, polytetrafluoroethylene isolating membrane 3, transmit coupling part 2, bolt head 4 is formed.Wherein, support 1 is formed by the nitinol alloy wire braiding, and the surface is network structure, and inside is hollow structure, and it mainly comprises the plate-like block head 6 that matches with the left atrium face and the cylindrical reference column 5 that is positioned in the left auricle is installed; Polytetrafluoroethylene isolating membrane 3 linings are gone in the support 1 and are sewn to by medical suture on the grid of support 1 periphery, play the effect that stops blood flow; Transmitting union joint 2 is positioned on the plate-like block head 6 on the support 1, it is a helicitic texture, effect is that stopper of the present utility model is linked to each other with the push rod transmission part, link to each other with corresponding apparatus when being convenient to perform the operation, the push rod that turns clockwise during application connects both, is rotated counterclockwise then to be separated from each other.Bolt head 4 is positioned at the center intersection of the end of cylindrical reference column, and it is formed that it is that support 1 braiding is sealed, and it can make whole stopper connect into the integral body of a closure, makes the stopper sound construction, and form is reasonable.
Cylindrical reference column 5 in plate-like block head 6 of the present utility model and the auricle has good shape memory function, is linear when being subjected to the external force tractive, and external force is recovered original-shape after removing immediately.
In zoopery and clinical practice, select the size of stopper according to left auricle radiography in transesophageal echocardiography inspection and the art.Usually selection stopper diameter should be bigger by 20%~40% than left auricle inlet diameter.Reach once more the radiography result according to the esophagus ultrasound kinetocardiogram and determine stopper implantation position and plugging effect.
The left atrial appendage occlusion device of implanting adopts bioactive molecule bag quilt, helps lend some impetus to the quick endothelialization on stopper surface after the implantation, avoids taking place stopper surface thrombosis.
Below in conjunction with concrete experimental result this utility model is further described.
Concrete zoopery embodiment is as follows:
5 male miniature pigs, body weight 23-28kg, average 24.6kg.
Whole intervention shutoff process is carried out under X line perspective, under the guiding of transesophageal echocardiography.The laboratory animal dorsal position is fixed in catheter bed.Patients Under Ketamine Anesthesia connects respirator, electrocardiograph after the tracheal intubation.Right femoral vein 10F venipuncture sheath, conventional atrial septal puncture, after arriving the left auricle position, postero-anterior position and right anterior oblique position 30 degree left auricle radiographies are understood left auricle size and shape, measure auricle inlet internal diameter, selection is than the stopper of the big 20%-40% diameter of auricle inlet internal diameter, extract guiding catheter and puncture sheath, discharge stopper and make its expansion, fill auricle.At the near-end and the distal injection contrast agent of device, estimating has contrast-agent-free to leak, if shutoff is incomplete, can reorientate or withdraw from or change stopper.The standard that stopper discharges fully is by left auricle radiography and transesophageal echocardiography determine that shutoff is complete, the tentative stability that spurs 1-2cm with definite device, the situation of radiography evaluation shutoff once more once more.If shutoff is complete, discharge stopper, operation finishes.
Experimental result: 5 animals, except that 1 because of the too much death of intraoperative hemorrhage, all the other 4 all survive.Put to death 1 respectively in 2 weeks of postoperative, 4 weeks, 8 weeks, the execution echocardiography that moves ahead, Bicuspid valve, pulmonary vein lobe blood flow are unaffected, put to death the back gross examination of skeletal muscle, all the stopper sealing is good, does not see displacement, does not have thrombosis around perusal stopper surface reaches, 4 when week stopper atrial surface surface area about 80% covered by endothelium, stopper atrial surface surface area is almost completely covered by endothelium during 8 weeks.
Below in conjunction with preparation of the present utility model and use this utility model is further described.
Left atrial appendage occlusion device of the present utility model is made of super elastic force nitinol alloy wire, polytetrafluoroethylene film and the transmission coupling part of the molecule covalency bag quilt of antithrombotic molecule and increase stopper surface endothelialization.The nitinol alloy wire of preparation support is the key of preparation this utility model stopper, its surface should adopt the long-pending method covalency bag of chemical vapors vapour by heparin, hirudin, fibronectin isoreactivity molecule, obviously reduce the thrombosis on stopper surface, quickened the endothelialization on stopper surface; The polytetrafluoroethylene isolating membrane serves as a contrast in the middle of the support, plays the effect that stops blood flow; The effect that transmits union joint be fixedly nitinol alloy wire with the duct that is connected with push rod is provided.
The single-deck shape that the outward appearance of a kind of novel left atrial appendage occlusion device of the present utility model is definite shape directly connects a cylinder, and the disk external diameter is bigger than cylindrical external diameter.It is in the form of annular discs that stopper is arranged in an end of left atrium, has fixed rustless steel to transmit union joint, links to each other by push rod during application, and the back that puts in place separates both by the counter-rotating push rod.Stopper has good shape memory function, is subjected to external force traction and is linear, and external force is recovered original-shape after removing immediately.
Support of the present utility model can be formed by certain route braiding on mould by nitinol alloy wire, puts into special mould, through the control treatment temperature, reaches needed super-elasticity and memory function.
3 layers of polytetrafluoroethylene isolating membrane of support 1 liner of the left atrial appendage occlusion device that this utility model provides, one deck is positioned at the discoid block head of the left room face of stopper, in addition two-layerly is positioned at cylindrical reference column, strengthens stopping the effect of blood flow.And 3 layers of polytetrafluoroethylene film and support appropriate section are stitched together with medical suture.Whole intervention shutoff process is carried out under the guiding of transesophageal echocardiography, and behind the atrial septal puncture, radiography is estimated the size and the shape of left auricle, selects the left atrial appendage occlusion device of suitable size.Behind the atrial septal puncture, extract guiding catheter and puncture sheath, discharge stopper and make its expansion, fill auricle.At the near-end and the distal injection contrast agent of device, estimating has contrast-agent-free to leak, if shutoff is incomplete, can reorientate or withdraw from or change stopper.The standard that stopper discharges fully is for complete by ultrasonic definite shutoff in radiography or the transesophageal echocardiography or the chambers of the heart, and tentative pulling 1-2cm is to determine the stability of device, and radiography is estimated the situation of shutoff once more.If shutoff is complete, can discharge stopper, finish operation.

Claims (5)

1, a kind of can be in left auricle automatic localized left atrial appendage occlusion device, comprise form by nitinol alloy wire braiding, the surface is for cancellated support (1) and be installed in isolating membrane (3) in the support (1), it is characterized in that described support (1) is linked to each other by the cylindrical reference column (5) of the plate-like block head (6) of hollow and hollow forms, and the external diameter of plate-like block head (6) is greater than the external diameter of cylindrical reference column (5); In plate-like block head (6) and cylindrical reference column (5), isolating membrane (3) is installed all; On plate-like block head (6) is got along well the one side that cylindrical reference column (5) links to each other, be equipped with and transmit union joint (2).
2, according to claim 1 can be in left auricle automatic localized left atrial appendage occlusion device, it is characterized in that the molecule fibronectin that the pan coating at the nitinol alloy wire of braided support (1) has antithrombotic molecular heparin, hirudin and increases endothelialization.
3, according to claim 1 can be in left auricle automatic localized left atrial appendage occlusion device, it is characterized in that described isolating membrane (3) is the polytetrafluoroethylene film.
4, according to claim 1 can be in left auricle automatic localized left atrial appendage occlusion device, it is characterized in that being provided with two layers of isolating membrane (3) at least at described cylindrical reference column (5).
5, according to claim 1 can be in left auricle automatic localized left atrial appendage occlusion device, it is characterized in that the edge of described isolating membrane (3) is sewn on cylindrical reference column (5) and the plate-like block head (6) by medical suture.
CN 200620068478 2006-01-16 2006-01-16 Auricula sinistra blocking device capable of automatic positioning in auricula sinitra Expired - Fee Related CN2820130Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200620068478 CN2820130Y (en) 2006-01-16 2006-01-16 Auricula sinistra blocking device capable of automatic positioning in auricula sinitra

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200620068478 CN2820130Y (en) 2006-01-16 2006-01-16 Auricula sinistra blocking device capable of automatic positioning in auricula sinitra

Publications (1)

Publication Number Publication Date
CN2820130Y true CN2820130Y (en) 2006-09-27

Family

ID=37016679

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200620068478 Expired - Fee Related CN2820130Y (en) 2006-01-16 2006-01-16 Auricula sinistra blocking device capable of automatic positioning in auricula sinitra

Country Status (1)

Country Link
CN (1) CN2820130Y (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100444811C (en) * 2006-01-16 2008-12-24 孔祥清 Automatically positioned left auricle block instrument
CN101884556A (en) * 2010-07-01 2010-11-17 西安交通大学 Magnetic device provided with support for cholangio-jejunostomy and end-to-side intestinal anastomosis
WO2016049991A1 (en) * 2014-09-29 2016-04-07 上海形状记忆合金材料有限公司 Left atrial appendage occlusion apparatus
CN105658148A (en) * 2013-06-26 2016-06-08 W.L.戈尔及同仁股份有限公司 Occlusive device
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
US11944537B2 (en) 2017-01-24 2024-04-02 4C Medical Technologies, Inc. Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve
US11957577B2 (en) 2017-01-19 2024-04-16 4C Medical Technologies, Inc. Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
US11992403B2 (en) 2020-03-06 2024-05-28 4C Medical Technologies, Inc. Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100444811C (en) * 2006-01-16 2008-12-24 孔祥清 Automatically positioned left auricle block instrument
CN101884556A (en) * 2010-07-01 2010-11-17 西安交通大学 Magnetic device provided with support for cholangio-jejunostomy and end-to-side intestinal anastomosis
CN101884556B (en) * 2010-07-01 2012-04-18 西安交通大学 Magnetic device provided with support for cholangio-jejunostomy and end-to-side intestinal anastomosis
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
CN105658148B (en) * 2013-06-26 2020-07-14 W.L.戈尔及同仁股份有限公司 Filling device
CN105658148A (en) * 2013-06-26 2016-06-08 W.L.戈尔及同仁股份有限公司 Occlusive device
WO2016049991A1 (en) * 2014-09-29 2016-04-07 上海形状记忆合金材料有限公司 Left atrial appendage occlusion apparatus
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US11826052B2 (en) 2015-05-14 2023-11-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US11957577B2 (en) 2017-01-19 2024-04-16 4C Medical Technologies, Inc. Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
US11944537B2 (en) 2017-01-24 2024-04-02 4C Medical Technologies, Inc. Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
US11992403B2 (en) 2020-03-06 2024-05-28 4C Medical Technologies, Inc. Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells

Similar Documents

Publication Publication Date Title
CN2820130Y (en) Auricula sinistra blocking device capable of automatic positioning in auricula sinitra
CN100444811C (en) Automatically positioned left auricle block instrument
Harrison et al. Correction of congenital diaphragmatic hernia in utero, V. Initial clinical experience
Wychulis et al. Acquired nonmalignant esophagotracheobronchial fistula: report of 36 cases
Giroud et al. Evolution of strategies for management of the patent arterial duct
Broaddus et al. Patent ductus arteriosus in dogs
Hauser et al. Transoesophageal echocardiography (TOE): contra-indications, complications and safety of perioperative TOE
Holt et al. Congenital atresia of the esophagus and tracheo-esophageal fistula
Baker et al. Gastrointestinal bleeding due to blue rubber bleb nevus syndrome: a case diagnosed by angiography
Levine et al. Anastomotic pseudoaneurysm of the ventricle after homograft placement in children
Yamaguchi et al. Surgical treatment of airway obstruction associated with congenital heart disease in infants and small children
CN203506819U (en) Visible balloon cannula for esophageal and gastric varices
CN201814605U (en) Asymmetric double-plate-type left auricle occluder
Gargiulo et al. Interrupted aortic arch and aortopulmonary window: one-stage repair in the first week of life
Robotham et al. A physiologic assessment of segmental bronchial atresia
Metsemakers et al. Spontaneous cholecystocutaneous abscess
Ho et al. The use of multiplane transesophageal echocardiography to evaluate residual patent ductus arteriosus during video-assisted thoracoscopy in adults
Chand et al. Perioperative management of the bariatric surgery patient
RU2701772C1 (en) Method of post-pneumonectomic syndrome treatment
Mirat et al. Secondary hypertension due to isolated interrupted aortic arch in a 60-year-old person–one-year follow up
Seghatol et al. Left‐Sided Endocarditis in Intravenous Drug Users: A Case Report and Review of the Literature
Porycka et al. Surgical management of cholecystoduodenal fistula complicated by ileus (Mirizzi syndrome type Vb). A case report
RU2698873C1 (en) Method of forming hepaticojejunostomy with high bile duct injury
Durmuş et al. Retrival of Embolized Atrial Septal Defekt Closure Device in the Left Iliac Artery
Chen et al. Bedside Pericardiocentesis under the Guidance of Transesophageal Echocardiography in a 13-Month-Old Boy.

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060927

Termination date: 20150116

EXPY Termination of patent right or utility model